Beer TM - Search Results

1

Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer.

Ferrari AC, Alumkal JJ, Stein MN, Taplin ME, Babb J, Barnett ES, Gomez-Pinillos A, Liu X, Moore D, DiPaola R, Beer TM. Ferrari AC, et al. Among authors: beer tm. Clin Cancer Res. 2019 Jan 1;25(1):52-63. doi: 10.1158/1078-0432.CCR-18-1589. Epub 2018 Sep 17. Clin Cancer Res. 2019. PMID: 30224345 Clinical Trial.

2

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer.

Beer TM, Pierce WC, Lowe BA, Henner WD. Beer TM, et al. Ann Oncol. 2001 Sep;12(9):1273-9. doi: 10.1023/a:1012258723075. Ann Oncol. 2001. PMID: 11697840 Free article. Clinical Trial.

3

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer.

Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Beer TM, et al. J Clin Oncol. 2003 Jan 1;21(1):123-8. doi: 10.1200/jco.2003.05.117. J Clin Oncol. 2003. PMID: 12506180 Clinical Trial.

4

High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.

Beer TM, Lemmon D, Lowe BA, Henner WD. Beer TM, et al. Cancer. 2003 Mar 1;97(5):1217-24. doi: 10.1002/cncr.11179. Cancer. 2003. PMID: 12599228 Free article.

5

Intermittent chemotherapy in metastatic androgen-independent prostate cancer.

Beer TM, Garzotto M, Henner WD, Eilers KM, Wersinger EM. Beer TM, et al. Br J Cancer. 2003 Sep 15;89(6):968-70. doi: 10.1038/sj.bjc.6601232. Br J Cancer. 2003. PMID: 12966410 Free PMC article. Clinical Trial.

6

Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer.

Beer TM, Garzotto M, Lowe BA, Ellis WJ, Montalto MA, Lange PH, Higano CS. Beer TM, et al. Clin Cancer Res. 2004 Feb 15;10(4):1306-11. doi: 10.1158/1078-0432.ccr-1021-03. Clin Cancer Res. 2004. PMID: 14977829 Clinical Trial.

7

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. Fromme EK, et al. Among authors: beer tm. J Clin Oncol. 2004 Sep 1;22(17):3485-90. doi: 10.1200/JCO.2004.03.025. J Clin Oncol. 2004. PMID: 15337796

8

Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer.

Beer TM, Garzotto M, Henner WD, Eilers KM, Wersinger EM. Beer TM, et al. Br J Cancer. 2004 Oct 18;91(8):1425-7. doi: 10.1038/sj.bjc.6602198. Br J Cancer. 2004. PMID: 15467765 Free PMC article.

9

High-dose calcitriol and carboplatin in metastatic androgen-independent prostate cancer.

Beer TM, Garzotto M, Katovic NM. Beer TM, et al. Am J Clin Oncol. 2004 Oct;27(5):535-41. doi: 10.1097/01.coc.0000136020.27904.9c. Am J Clin Oncol. 2004. PMID: 15596926 Clinical Trial.

10

Phase II study of transdermal estradiol in androgen-independent prostate carcinoma.

Bland LB, Garzotto M, DeLoughery TG, Ryan CW, Schuff KG, Wersinger EM, Lemmon D, Beer TM. Bland LB, et al. Among authors: beer tm. Cancer. 2005 Feb 15;103(4):717-23. doi: 10.1002/cncr.20857. Cancer. 2005. PMID: 15641029 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters